Exelixis
EXEL
#1766
Rank
C$16.90 B
Marketcap
C$67.27
Share price
-3.32%
Change (1 day)
14.41%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company